MethodSense Launches Capital & Investment Strategy Advisory for the MedTech Sector
-
MethodSense Launches Capital & Investment Strategy Advisory for the MedTech Sector
New practice aligns regulatory intelligence with fundable growth and confident capital deployment… MORRISVILLE, NC – March 10, 2026, MethodSense, a regulatory and quality advisory firm serving the medical device industry, today announced the launch of its Capital & Investment Strategy advisory practice, designed to align regulatory intelligence with capital decisions across the MedTech lifecycle. As…
-
MethodSense Receives Global Reach Award for Trade Excellence from NC Governor Stein and EDPNC
Honored for advancing North Carolina’s global life sciences presence through regulatory intelligence and compliance technology… MORRISVILLE, NC – March 05, 2026, MethodSense, a North Carolina–based regulatory and quality advisory firm serving the global life sciences industry, has been recognized for Export Trade Excellence by Josh Stein, in partnership with the Economic Development Partnership of North…
-
MethodSense Named Top 25 Life Science Technology Vendors
CIO Applications recognizes MethodSense as Top Life Science Technology Vendors Amidst technological innovations, regulatory changes, and increased reliance on patient-centric models, there seems to be a multitude of growth opportunities for life sciences companies. Life sciences undoubtedly remain one of the industries that see rapid technological evolution ahead of them. Even though life sciences has…